Does PharmEasy have an IPO?

PharmEasy is preparing to launch its IPO

How do I buy PharmEasy shares?

One can buy PharmEasy shares online through our website, or investors can call us and confirm the deal with our Relationship Manager at 966999944, 7999252591, or 0731-4025544.

Is PharmEasy a profitable company?

No, the company has not yet been profitable because PharmEasy suffered a loss of 39,924.96 million in FY 2022.

What is Phrameasy share price today?

Pharmeasy share price used to change every day like other companies share prices. To find out the most recent Phrameasy share price

Pharmeasy Share Price - API Holdings Shares [Cheapest Price]

Hot Deals:

a v thomas 13,300.00 (1.53 %) adtech 27.05 (0.19 %) agarwal bolts 1,210.00 (0.75 %) amol minechem 620.00 (1.64 %) anand i-power 20.00 anglo french 370.00 (-2.37 %) api holdings ltd 24.10 (0.42 %) arkfin investments 50.00 arohan 170.00 (-0.58 %) assam carbon 208.00 (-0.95 %) associated pigments 42.01 (0.02 %) atlas copco 10,000.00 (1.01 %) auckland international 129.00 (-0.77 %) axles 181.00 (0.56 %) b9 beverages limited 691.00 (-1.29 %) balmer lawrie 197.00 (-1.50 %) bharat hotels 150.00 (0.67 %) bima mandi 700.00 c & s electric 471.00 (0.21 %) capgemini 9,900.00 (-1.00 %) care health 143.00 (-0.69 %) carrier aircon 260.00 (1.96 %) cial 174.00 (-0.57 %) csfbl 321.00 (0.31 %) csk 163.00 (-2.98 %) dalmia refract 118.00 (-1.67 %) dsp merrill lynch 1,000.00 east india pharma 43.90 (-0.23 %) eaton fluid 415.00 (0.24 %) electronica plastic 4,110.00 (0.24 %) elgi ultra 400.00 elofic 1,925.00 (0.84 %) esl steel 36.00 (-2.70 %) fincare business 43.00 fincare sfbl 191.00 (0.53 %) fino paytech 149.00 (-0.67 %) flipkart india 231,001.00 (0.00 %) frick india 2,710.00 (0.37 %) gkn drive 1,111.00 (1.00 %) go digit general insurance ltd 354.00 (1.14 %) godavari bio 71.00 (1.43 %) hdbfsl 630.00 (1.61 %) hdfc ergo 370.00 (1.70 %) hdfc securities 11,500.00 (1.50 %) hella india 380.00 (1.33 %) hero fincorp 840.00 (-1.18 %) hicks 1,710.00 (0.59 %) hira ferro 120.00 (-0.83 %) honeywell electrical 3,333.00 (-1.97 %) icex 0.10 (-0.10 %) imagine marketing 800.00 (-1.84 %) incred financial 100.00 india carbon 945.00 (-0.53 %) india exposition 144.00 (-1.37 %) indian potash 1,600.00 (-1.84 %) indofil 710.00 (-2.34 %) infinite computer 700.00 inkel 12.00 (-1.64 %) ixigo 80.00 (1.27 %) jana sfbl 75.00 kel 540.00 (1.89 %) kial 105.00 (-1.87 %) kurlon limited 310.00 (1.31 %) lava 111.00 (0.91 %) manipal housing 72.50 (0.69 %) manjushree tech 900.00 (-1.10 %) martin & harris 1,170.00 (-2.50 %) merino 2,600.00 (-3.70 %) minosha 282.00 (0.71 %) mitsubishi heavy 355.00 (1.43 %) mkcl 304.00 (-0.65 %) mobikwik 390.00 (-2.50 %) mohan meakin 1,330.00 (0.38 %) mohfl 8.10 (1.25 %) msei 1.00 (1.01 %) msil 57.00 (1.79 %) nayara energy 150.00 (-1.32 %) nayara energy ncd 255.00 (-1.92 %) ncdex 275.00 ncl buildtek 180.00 (2.86 %) ncl holdings 53.00 (1.92 %) nse 3,100.00 (-0.80 %) oravel stays limited 64.00 (-1.54 %) orbis financial 81.00 (1.25 %) oswal minerals 65.00 (1.56 %) otis 3,600.00 (-2.70 %) panasonic appliances 295.00 (0.68 %) panasonic avc 29.10 (0.34 %) paymate india 584.00 (0.69 %) philips 979.00 (-1.11 %) philips domestic 569.00 (-0.18 %) pnb metlife 70.00 proyuga adtech 25.00 purity flexpack 20.00 ramaraju surgical 306.00 (-2.24 %) rasoi 31,500.00 (0.32 %) reliance gic 340.00 resins plastics 414.00 (1.97 %) ring plus 404.00 (-0.25 %) rrl 2,280.00 (-0.87 %) sab miller 305.00 (0.66 %) sbi funds 880.00 (-2.22 %) scottish assam 443.00 (-1.56 %) shriram life 261.00 (0.38 %) sigachi lab 40.10 (0.25 %) signify 1,161.00 (0.96 %) simpson & company 3,500,000.00 smile micro 52.00 (-1.89 %) sportskeeda 3,303.00 sterlite power 430.00 (1.18 %) studds 850.00 (-2.30 %) svsml 430.00 (-2.27 %) t stanes 729.00 (1.25 %) tata capital 56.00 (1.82 %) tata tech 840.00 (0.60 %) teesta agro 81.00 (1.25 %) trl krosaki 1,200.00 (-1.96 %) utkarsh coreinvest 137.00 (0.74 %) vikram solar 55.50 (-0.89 %)

Company Name

PharmEasy

Last Traded Price (LTP)

24.10

% Change

+ 0.42 %

Scrip Name

API Holdings Ltd

ISIN No.

INE0DJ201029

PAN No.

AASCA1201E

Face Value

No. of Outstanding Shares

5,530,566,129

Market Capitalization

13,328.66 Crore

Book value

12.698

P/BV

1.8979

EPS

-7.219

PE ratio

Available on

nsdlcdsl

ROFR Required

PharmEasy Share Price & Unlisted Shares - Company Overview

API Holdings Limited formerly known as API Holdings Private Limited is an unlisted public limited company, incorporated on 31st March 2019.

API Holdings Limited is India's largest digital healthcare platform in terms of the gross merchandise value (GMV) of products and services sold.

The Company is engaged in diversified businesses primarily trading pharmaceutical and cosmetic goods, licensing of internet portals or mobile applications related to sales and distribution of pharmaceutical and cosmetic goods, diagnostic services, teleconsulting, etc.

API Holdings Ltd, the parent company of online pharmacy and health tech platform PharmEasy, which recently withdrew its IPO due to "market conditions and external factors”, recorded a larger loss for FY22 than the previous year. Pharmeasy share price has grown from a distributor of medicinal products to a fully integrated, digital healthcare platform that offers teleconsultation, medical equipment, and pharmaceuticals.

PharmEasy Share Price, Unlisted Share Details as of March 31, 2022

PharmEasy Outstanding Shares:	5,530,566,129
Face Value of PharmEasy Unlisted Share:	Rs. 1 Per Equity Share
ISIN of PharmEasy Unlisted Share:	INE0DJ201029
Lot Size of PharmEasy Unlisted Share:	1000 Shares
PharmEasy Share Price:	Best in Industry
PAN Number of PharmEasy:	AASCA1201E

PharmEasy Incorporation Details

PharmEasy CIN Number	U60100MH2019PLC323444

PharmEasy Registration Date	31-Mar-19

Category / Sub-Category of PharmEasy	Limited by Shares/ Non-govt company

PharmEasy Registered Office Address	Unit No 104, Marwahs Complex 4, Marwah Estate, Krishnalal, Marwah Marg, Mumbai - 400072


PharmEasy Registrar & Transfer Agent Address and Contact Details	Link InTime India Private Limited, 902, 9TH Floor, Raheja Plaza 1, B Wing, Opposite R City Mall, L.B.S Marg, Ghatkopar, Mumbai - 400086

PharmEasy Board of Directors

Mr. Aditya Puri, Chairman, Non-Executive Director

Mr. Deepak Vaidya, Independent, Non-Executive Director

Mr. Ankur Thadani, Non-Executive Director

Mr. Ashutosh Sharma, Non-Executive Director

Ms. Vineeta Rai, Independent, Non-Executive Director

Dr. Jaydeep Tank, Independent, Non-Executive Director

Mr. Subramaniam Somasundaram, Independent, Non-Executive Director

Mr. Siddharth Shah, MD, and CEO

Mr. Harsh Parekh, Whole-time Director

Mr. Dharmil Sheth, Whole-time Director

PharmEasy Subsidiary & Associate Companies

S. No.	Name of the Company	Holding/ Subsidiary/ Associate	% of Shares held
1.	Threpsi Solutions Private Limited	Subsidiary	100
2.	ARZT and Health Private Limited	Subsidiary	100
3.	Ascent Wellness and Pharma Solutions Private Limited	Subsidiary	100
4.	Docon Technologies Private Limited	Subsidiary	100
5.	Thyrocare Technologies Limited	Subsidiary	71.18
6.	AKP Healthcare Private Limited	Subsidiary	51
7.	Ayro Retail Solutions Private Limited	Subsidiary	100
8.	Venkatesh Medico Private Limited	Subsidiary	51
9.	Instinct Innovation s Private Limited	Subsidiary	100
10.	Eastern Agencies Healthcare Private Limited	Subsidiary	100
11.	MARG ERP Ltd	Associate	99.23
12.	Equinox Labs Limited	Associate	209.2
13.	Impex Healthcare Private Limited	Associate	90.30

PharmEasy Industry Outlook

According to a Red Seer Report, the company has a target addressable market of Rs. 10.4 trillion ($139 billion) as of 2020, which corresponds to the size of the entire Indian Healthcare market in 2020. The target addressable market is expected to grow at a 14% CAGR to reach $20 trillion ($266 billion) by 2025.

Online pharmacy-led play: Online pharmacies, consisting of at-home delivery of prescription medicines, covered 63% of the market pre-COVID in 2019 and held 55% of the market in 2020, despite the disruption in pharma supply. eOTC is the second-largest segment, constituting doorstep delivery of generic medicines and health products. It accounted for 26% of the market share before COVID, which soared to 35% in 2020, owing to the high demand for COVID-related OTC products.

Large headroom ahead: Despite the high growth, digital penetration in health (across pharma, OTC, diagnostics, and consultation) is only at 2%, indicating a very nascent stage of penetration. For example, online pharmacy penetration in India was 2.3% in 2020, significantly lower than in China (10-15%) and the United States (30-35%).

Overview Balance Sheet P&L Account Cash Flow